Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Hemodynamic Stability During Carotid Endarterectomy
NCT07597109Phase 4Not yet recruiting
- Sponsor
- Insel Gruppe
- Start
- Sep 2026
- Primary completion
- Sep 2026
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of dexmedetomidine in steno-occlusive disease, sponsored by Insel Gruppe. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
steno-occlusive disease
Beyond the preview
Go deeper on NCT07597109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07597109.